Appendix 2. Description of interventions (part 1).

Characteris- tic	Bundy R, 2008	Chen LL, 2002	Deng YM, 2006	Ding W, 1999	Feng XY, 2006	Francini-Pesenti F, 2008	Hua D, 2008
Intervention (s) [route, frequency, to- tal dose/day]	I: Artichoke leaf extract (Cynara Scolymus) orally, daily, 1280 mg/day	I: Xuezhikang orally, 3 times a day, 3.6 g/day	I: Xuezhikang orally, 2 times a day, 1.2 g/day	I: Xuezhikang orally, 2 times a day, 1.2 g/day	I: Xuezhikang orally, 2 times a day, 2.4 g/day	I: Policosanol orally, daily, 10 mg/day	I: Xuezhikang orally, 2 times a day, 1.2 g/day
Control(s) [route, frequency, to- tal dose/day]	C: placebo orally, daily, 1280 mg/day	C: simvastatin orally, daily, 10 mg/day	C: simvastatin orally, daily, 20 mg/day	C: simvastatin, orally, daily, 10 mg/day	C: inositol nicotinate orally, 3 times a day, 0.6 g/day	C: placebo orally, daily, 10 mg/day	C: simvastatin orally, daily, 10 mg/day

Footnotes

C: control; I: intervention